Viewing Study NCT00975806


Ignite Creation Date: 2025-12-26 @ 1:18 PM
Ignite Modification Date: 2025-12-29 @ 4:19 PM
Study NCT ID: NCT00975806
Status: TERMINATED
Last Update Posted: 2019-11-25
First Post: 2009-09-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma
Sponsor: Celgene
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-09-01
Start Date Type: ACTUAL
Primary Completion Date: 2011-10-01
Primary Completion Date Type: ACTUAL
Completion Date: 2011-10-01
Completion Date Type: ACTUAL
First Submit Date: 2009-09-09
First Submit QC Date: None
Study First Post Date: 2009-09-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-12-17
Results First Submit QC Date: None
Results First Post Date: 2014-12-29
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-11-14
Last Update Post Date: 2019-11-25
Last Update Post Date Type: ACTUAL